The debate over the safety of gadolinium-based contrast agents for MRI shows no sign of going away, and U.S.-style lawsuits filed against radiologists and vendors in Europe is now a distinct possibility. Dr. Alexander Radbruch, JD, head of neuro-oncologic imaging at the German Cancer Research Center in Heidelberg and University Hospital Essen, is both a lawyer and a radiologist, and he presents his views and ideas on this controversial topic.
The debate over the safety of gadolinium-based contrast agents for MRI shows no sign of going away, and U.S.-style lawsuits filed against radiologists and vendors in Europe is now a distinct possibility. Dr. Alexander Radbruch, JD, head of neuro-oncologic imaging at the German Cancer Research Center in Heidelberg and University Hospital Essen, is both a lawyer and a radiologist, and he presents his views and ideas on this controversial topic.Video from ECR 2018: Alexander Radbruch on gadolinium retention
Feb 28, 2018
Latest in Medicolegal
Radiologist faces strong criticism in negligence case
September 11, 2024
Penn. radiologist charged with child sexual exploitation
September 4, 2024